What is Transcat's earnings per share (EPS)?

Transcat (TRNS) reported diluted earnings per share of $0.57 for fiscal year 2026. This represents a -63.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Transcat Financials

TRNS

Source SEC Filings (10-K/10-Q) Data as of Mar 28, 2026 Currency USD FYE March

This page shows Transcat (TRNS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRNS FY2025 2026-05-27

Transcat’s acquisition-led expansion is enlarging the asset base faster than sales, while cash conversion remains notably strong.

From FY2024 to FY2025, EBITDA increased to $36.4M even as operating income slipped to $17.9M, a gap widened by heavier depreciation and amortization. With operating cash flow at $39.0M and free cash flow at $25.8M, the newer asset base is weighing more on reported margins than on actual cash generation.

The balance sheet shows acquisition-led expansion: goodwill reached $176.9M while total assets rose to $385.2M, making a large share of the company’s resources intangible rather than cash or working capital. Debt also rebuilt to $30.9M, yet liabilities of $98.4M remain well below equity, so the expansion has not been financed with extreme leverage.

Gross margin stayed near 32.0% in FY2024 and FY2025, but operating margin slipped to 6.4% in FY2025, so the squeeze is happening below the gross-profit line rather than in core pricing or mix. That pattern fits a business carrying more overhead and amortization as it scales, not one whose basic unit economics are breaking down.

Financial Health Signals

Financial Health Score 56/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Transcat's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Transcat has an operating margin of 4.0%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 62/100, indicating healthy but not exceptional operating efficiency. This is down from 6.4% the prior year.

Growth

Transcat's revenue surged 19.2% year-over-year to $331.9M, reflecting rapid business expansion. This strong growth earns a score of 72/100.

Leverage

Transcat has elevated debt relative to equity (D/E of 0.33), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 26/100, reflecting increased financial risk.

Liquidity

With a current ratio of 2.33, Transcat holds $2.33 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Cash Flow

Transcat has a free cash flow margin of 5.9%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Transcat's ROE of 1.8% shows moderate profitability relative to equity, earning a score of 53/100. This is down from 5.1% the prior year.

Altman Z-Score Safe

3.95

Transcat scores 3.95, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($825.3M) relative to total liabilities ($179.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Transcat passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

6.48x

For every $1 of reported earnings, Transcat generates $6.48 in operating cash flow ($34.9M OCF vs $5.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.9x

Transcat earns $2.9 in operating income for every $1 of interest expense ($13.3M vs $4.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$331.9M

YoY+19.2%

5Y CAGR+13.9%

10Y CAGR+10.5%

Transcat generated $331.9M in revenue in fiscal year 2026. This represents an increase of 19.2% from the prior year.

EBITDA

$39.4M

YoY+8.2%

5Y CAGR+16.2%

10Y CAGR+14.4%

Transcat's EBITDA was $39.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.2% from the prior year.

Net Income

$5.4M

YoY-63.0%

5Y CAGR-7.2%

10Y CAGR+2.7%

Transcat reported $5.4M in net income in fiscal year 2026. This represents a decrease of 63.0% from the prior year.

EPS (Diluted)

$0.57

YoY-63.7%

5Y CAGR-11.2%

10Y CAGR-0.2%

Transcat earned $0.57 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 63.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$19.6M

YoY-24.2%

5Y CAGR+2.8%

10Y CAGR+11.0%

Transcat generated $19.6M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 24.2% from the prior year.

Cash & Debt

$4.9M

YoY+225.8%

5Y CAGR+54.6%

10Y CAGR+22.7%

Transcat held $4.9M in cash against $99.9M in long-term debt as of fiscal year 2026.

Dividends Per Share

N/A

Shares Outstanding

YoY+0.2%

5Y CAGR+4.6%

10Y CAGR+3.0%

Transcat had 9M shares outstanding in fiscal year 2026. This represents an increase of 0.2% from the prior year.

Margins & Returns

Gross Margin

32.6%

YoY+0.5pp

5Y CAGR+6.0pp

10Y CAGR+8.8pp

Transcat's gross margin was 32.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the prior year.

Operating Margin

4.0%

YoY-2.4pp

5Y CAGR-2.4pp

10Y CAGR-1.2pp

Transcat's operating margin was 4.0% in fiscal year 2026, reflecting core business profitability. This is down 2.4 percentage points from the prior year.

Net Margin

1.6%

YoY-3.6pp

5Y CAGR-2.9pp

10Y CAGR-1.8pp

Transcat's net profit margin was 1.6% in fiscal year 2026, showing the share of revenue converted to profit. This is down 3.6 percentage points from the prior year.

Return on Equity

1.8%

YoY-3.3pp

5Y CAGR-8.6pp

10Y CAGR-8.8pp

Transcat's ROE was 1.8% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 3.3 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$469K

YoY-86.8%

5Y CAGR-31.2%

10Y CAGR+20.4%

Transcat spent $469K on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 86.8% from the prior year.

Capital Expenditures

$15.3M

YoY+15.9%

5Y CAGR+18.2%

10Y CAGR+14.1%

Transcat invested $15.3M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 15.9% from the prior year.

TRNS Income Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Revenue	$331.9M+19.2%	$278.4M+7.3%	$259.5M+12.5%	$230.6M+12.5%	$205.0M+18.2%	$173.3M
Cost of Revenue	$223.6M+18.3%	$189.0M+7.6%	$175.7M+8.3%	$162.2M+10.7%	$146.5M+15.2%	$127.2M
Gross Profit	$108.3M+21.1%	$89.5M+6.7%	$83.8M+22.6%	$68.4M+17.0%	$58.4M+26.7%	$46.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$52.3M+36.7%	$38.2M+8.3%	$35.3M+29.1%	$27.3M+15.6%	$23.6M+36.7%	$17.3M
Operating Income	$13.3M-25.8%	$17.9M-9.6%	$19.8M+21.7%	$16.2M+14.9%	$14.1M+27.7%	$11.1M
Interest Expense	$4.6M+476.7%	$798K-56.5%	$1.8M-24.1%	$2.4M+198.4%	$810K	N/A
Income Tax	$2.6M-31.4%	$3.8M-20.5%	$4.8M+71.2%	$2.8M+54.6%	$1.8M-17.4%	$2.2M
Net Income	$5.4M-63.0%	$14.5M+6.4%	$13.6M+27.7%	$10.7M-6.1%	$11.4M+46.1%	$7.8M
EPS (Diluted)	$0.57-63.7%	$1.57-3.7%	$1.63+16.4%	$1.40-6.7%	$1.50+45.6%	$1.03

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$89.3M+6.5%	$83.9M+1.9%	$82.3M+7.7%	$76.4M-0.9%	$77.1M+15.5%	$66.8M-1.6%	$67.8M+1.7%	$66.7M
Cost of Revenue	$58.9M+0.4%	$58.6M+5.6%	$55.5M+9.7%	$50.6M-1.2%	$51.2M+8.8%	$47.1M+1.0%	$46.6M+5.8%	$44.1M
Gross Profit	$30.5M+20.7%	$25.3M-5.6%	$26.8M+3.6%	$25.8M-0.4%	$25.9M+31.7%	$19.7M-7.2%	$21.2M-6.4%	$22.7M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$14.9M+8.3%	$13.8M+9.0%	$12.6M+15.2%	$11.0M+12.7%	$9.7M+2.9%	$9.5M+1.8%	$9.3M-4.8%	$9.8M
Operating Income	$4.3M+4822.7%	$88K-97.5%	$3.5M-34.3%	$5.3M-23.1%	$6.9M+230.5%	$2.1M-43.8%	$3.7M-26.8%	$5.1M
Interest Expense	$1.4M-8.3%	$1.5M+18.4%	$1.3M+181.4%	$451K-4.2%	$471K+136.7%	$199K+161.8%	$76K+46.2%	$52K
Income Tax	$887K+362.4%	-$338K-144.5%	$760K-41.7%	$1.3M-27.2%	$1.8M+132.1%	$772K+80.8%	$427K-47.9%	$820K
Net Income	$1.9M+276.8%	-$1.1M-186.8%	$1.3M-61.1%	$3.3M-26.9%	$4.5M+89.4%	$2.4M-28.3%	$3.3M-25.5%	$4.4M
EPS (Diluted)	N/A	$-0.12-185.7%	$0.14-60.0%	$0.35	N/A	$0.25-28.6%	$0.35-27.1%	$0.48

TRNS Balance Sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Total Assets	$480.5M+24.7%	$385.2M+34.0%	$287.6M+46.9%	$195.7M+10.1%	$177.8M+34.5%	$132.1M
Current Assets	$92.5M+18.5%	$78.0M-25.8%	$105.2M+55.6%	$67.6M+13.2%	$59.7M+22.0%	$48.9M
Cash & Equivalents	$4.9M+225.8%	$1.5M-92.3%	$19.6M+1183.2%	$1.5M+9.7%	$1.4M+149.3%	$560K
Inventory	$13.7M-5.4%	$14.5M-16.9%	$17.4M+2.9%	$16.9M+33.2%	$12.7M+9.2%	$11.6M
Accounts Receivable	$65.2M+16.5%	$55.9M+17.1%	$47.8M+6.9%	$44.7M+12.5%	$39.7M+17.0%	$34.0M
Goodwill	$218.2M+23.3%	$176.9M+67.6%	$105.6M+52.2%	$69.4M+6.6%	$65.1M+50.4%	$43.3M
Total Liabilities	$179.9M+82.9%	$98.4M+57.7%	$62.4M-35.1%	$96.1M+4.9%	$91.6M+60.6%	$57.0M
Current Liabilities	$39.6M+16.4%	$34.0M+1.6%	$33.5M+18.3%	$28.3M+2.2%	$27.7M+10.2%	$25.1M
Long-Term Debt	$99.9M+223.3%	$30.9M+1600.2%	$1.8M-96.1%	$46.9M+1.2%	$46.3M+164.6%	$17.5M
Total Equity	$300.6M+4.8%	$286.9M+27.4%	$225.2M+126.0%	$99.6M+15.6%	$86.2M+14.8%	$75.1M
Retained Earnings	$97.8M+5.7%	$92.5M+15.5%	$80.1M+15.8%	$69.2M+17.7%	$58.7M+11.9%	$52.5M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$480.5M+1.6%	$472.9M-2.5%	$484.9M+23.5%	$392.5M+1.9%	$385.2M-0.2%	$386.0M+19.3%	$323.6M0.0%	$323.7M
Current Assets	$92.5M+14.4%	$80.8M-5.8%	$85.7M+7.6%	$79.7M+2.1%	$78.0M+1.9%	$76.6M-19.6%	$95.2M+1.0%	$94.3M
Cash & Equivalents	$4.9M+42.4%	$3.5M-31.7%	$5.1M+173.1%	$1.9M+22.7%	$1.5M-67.3%	$4.6M-80.5%	$23.8M+5.1%	$22.7M
Inventory	$13.7M+6.1%	$12.9M-1.2%	$13.1M-15.1%	$15.4M+6.3%	$14.5M+5.0%	$13.8M-11.3%	$15.5M-14.2%	$18.1M
Accounts Receivable	$65.2M+10.9%	$58.7M-6.1%	$62.6M+8.5%	$57.7M+3.1%	$55.9M+8.4%	$51.6M+5.5%	$48.9M+1.6%	$48.2M
Goodwill	$218.2M0.0%	$218.3M0.0%	$218.4M+23.3%	$177.1M+0.1%	$176.9M+0.2%	$176.6M+27.9%	$138.1M0.0%	$138.1M
Total Liabilities	$179.9M+2.1%	$176.1M-7.0%	$189.5M+89.5%	$100.0M+1.7%	$98.4M-6.3%	$104.9M+91.5%	$54.8M-10.7%	$61.4M
Current Liabilities	$39.6M+8.2%	$36.6M+3.7%	$35.3M+29.4%	$27.3M-19.9%	$34.0M+7.4%	$31.7M+19.4%	$26.5M-16.6%	$31.8M
Long-Term Debt	$99.9M0.0%	$99.9M-10.7%	$111.9M+237.2%	$33.2M+7.4%	$30.9M-21.8%	$39.5M+6353.6%	$612K-49.8%	$1.2M
Total Equity	$300.6M+1.3%	$296.8M+0.5%	$295.4M+1.0%	$292.5M+2.0%	$286.9M+2.1%	$281.1M+4.6%	$268.8M+2.5%	$262.3M
Retained Earnings	$97.8M+2.0%	$95.8M-1.2%	$97.0M+1.2%	$95.8M+3.5%	$92.5M+5.0%	$88.1M+2.6%	$85.9M+2.8%	$83.5M

TRNS Cash Flow Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	$34.9M-10.6%	$39.0M+19.5%	$32.6M+92.4%	$17.0M-3.8%	$17.6M-25.5%	$23.6M
Capital Expenditures	$15.3M+15.9%	$13.2M-0.6%	$13.3M+41.1%	$9.4M-7.3%	$10.2M+53.4%	$6.6M
Free Cash Flow	$19.6M-24.2%	$25.8M+33.4%	$19.3M+156.5%	$7.5M+1.0%	$7.5M-56.1%	$17.0M
Investing Cash Flow	-$97.8M-16.5%	-$84.0M-101.6%	-$41.7M-125.1%	-$18.5M+53.5%	-$39.9M-292.6%	-$10.2M
Financing Cash Flow	$66.5M+147.6%	$26.9M-2.0%	$27.4M+3027.7%	$876K-96.3%	$23.7M+287.2%	-$12.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$469K-86.8%	$3.6M-27.3%	$4.9M+997.5%	$447K-93.3%	$6.7M+119.2%	$3.0M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$6.2M-48.9%	$12.1M-5.7%	$12.9M+255.5%	$3.6M-65.9%	$10.6M-15.6%	$12.6M	N/A	$8.9M
Capital Expenditures	$3.6M+34.0%	$2.7M-39.6%	$4.4M-3.6%	$4.6M+70.6%	$2.7M-6.1%	$2.9M	N/A	$3.7M
Free Cash Flow	$2.6M-72.4%	$9.5M+12.0%	$8.4M+966.6%	-$975K-112.3%	$7.9M-18.5%	$9.7M	N/A	$5.3M
Investing Cash Flow	-$3.6M-34.1%	-$2.7M+96.9%	-$87.0M-1791.2%	-$4.6M-13.9%	-$4.0M+94.4%	-$72.0M	N/A	-$4.1M
Financing Cash Flow	-$488K+96.0%	-$12.2M-115.8%	$77.2M+3869.6%	$1.9M+120.6%	-$9.4M-123.8%	$39.7M	N/A	-$1.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$372K+2961.5%	-$13K-111.8%	$110K	$0-100.0%	$357K+96.2%	$182K	N/A	$1.6M

TRNS Financial Ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Gross Margin	32.6%+0.5pp	32.1%-0.2pp	32.3%+2.7pp	29.6%+1.1pp	28.5%+1.9pp	26.6%
Operating Margin	4.0%-2.4pp	6.4%-1.2pp	7.6%+0.6pp	7.0%+0.1pp	6.9%+0.5pp	6.4%
Net Margin	1.6%-3.6pp	5.2%-0.1pp	5.3%+0.6pp	4.6%-0.9pp	5.5%+1.1pp	4.5%
Return on Equity	1.8%-3.3pp	5.1%-1.0pp	6.1%-4.7pp	10.7%-2.5pp	13.2%+2.8pp	10.4%
Return on Assets	1.1%-2.6pp	3.8%-1.0pp	4.8%-0.7pp	5.5%-0.9pp	6.4%+0.5pp	5.9%
Current Ratio	2.33+0.0	2.29-0.8	3.14+0.8	2.39+0.2	2.15+0.2	1.95
Debt-to-Equity	0.33+0.2	0.11+0.1	0.01-0.5	0.47-0.1	0.54+0.3	0.23
FCF Margin	5.9%-3.4pp	9.3%+1.8pp	7.4%+4.2pp	3.3%-0.4pp	3.6%-6.2pp	9.8%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	34.1%+4.0pp	30.1%-2.4pp	32.5%-1.3pp	33.8%+0.2pp	33.6%+4.1pp	29.5%-1.8pp	31.3%-2.7pp	34.0%
Operating Margin	4.9%+4.8pp	0.1%-4.2pp	4.3%-2.7pp	7.0%-2.0pp	9.0%+5.8pp	3.1%-2.4pp	5.5%-2.1pp	7.6%
Net Margin	2.2%+3.5pp	-1.3%-2.9pp	1.5%-2.7pp	4.3%-1.5pp	5.8%+2.3pp	3.5%-1.3pp	4.8%-1.8pp	6.6%
Return on Equity	0.7%+1.0pp	-0.4%-0.8pp	0.4%-0.7pp	1.1%-0.4pp	1.6%+0.7pp	0.8%-0.4pp	1.2%-0.5pp	1.7%
Return on Assets	0.4%+0.6pp	-0.2%-0.5pp	0.3%-0.6pp	0.8%-0.3pp	1.2%+0.5pp	0.6%-0.4pp	1.0%-0.3pp	1.4%
Current Ratio	2.33+0.1	2.21-0.2	2.43-0.5	2.92+0.6	2.29-0.1	2.42-1.2	3.59+0.6	2.96
Debt-to-Equity	0.330.0	0.34-0.0	0.38+0.3	0.110.0	0.11-0.0	0.14+0.1	0.000.0	0.00
FCF Margin	2.9%-8.4pp	11.3%+1.0pp	10.3%+11.6pp	-1.3%-11.6pp	10.3%-4.3pp	14.6%	N/A	7.9%

Similar Companies

Target Hospitality Corp TH

$1.8B

Blacksky Technology Inc BKSY

$948.1M

Cass Info Sys CASS

$665.6M

Eastman Kodak KODK

$804.8M

Brightview Holdings BV

$1.3B

Frequently Asked Questions

What is Transcat's annual revenue?

Transcat (TRNS) reported $331.9M in total revenue for fiscal year 2026. This represents a 19.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Transcat's revenue growing?

Transcat (TRNS) revenue grew by 19.2% year-over-year, from $278.4M to $331.9M in fiscal year 2026.

Is Transcat profitable?

Yes, Transcat (TRNS) reported a net income of $5.4M in fiscal year 2026, with a net profit margin of 1.6%.

What is Transcat's EBITDA?

Transcat (TRNS) had EBITDA of $39.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Transcat have?

As of fiscal year 2026, Transcat (TRNS) had $4.9M in cash and equivalents against $99.9M in long-term debt.

What is Transcat's gross margin?

Transcat (TRNS) had a gross margin of 32.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Transcat's operating margin?

Transcat (TRNS) had an operating margin of 4.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Transcat's net profit margin?

Transcat (TRNS) had a net profit margin of 1.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Transcat's return on equity (ROE)?

Transcat (TRNS) has a return on equity of 1.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Transcat's free cash flow?

Transcat (TRNS) generated $19.6M in free cash flow during fiscal year 2026. This represents a -24.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Transcat's operating cash flow?

Transcat (TRNS) generated $34.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Transcat's total assets?

Transcat (TRNS) had $480.5M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Transcat's capital expenditures?

Transcat (TRNS) invested $15.3M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does Transcat buy back shares?

Yes, Transcat (TRNS) spent $469K on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Transcat have outstanding?

Transcat (TRNS) had 9M shares outstanding as of fiscal year 2026.

What is Transcat's current ratio?

Transcat (TRNS) had a current ratio of 2.33 as of fiscal year 2026, which is generally considered healthy.

What is Transcat's debt-to-equity ratio?

Transcat (TRNS) had a debt-to-equity ratio of 0.33 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Transcat's return on assets (ROA)?

Transcat (TRNS) had a return on assets of 1.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Transcat's Altman Z-Score?

Transcat (TRNS) has an Altman Z-Score of 3.95, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Transcat's Piotroski F-Score?

Transcat (TRNS) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Transcat's earnings high quality?

Transcat (TRNS) has an earnings quality ratio of 6.48x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Transcat cover its interest payments?

Transcat (TRNS) has an interest coverage ratio of 2.9x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Transcat?

Transcat (TRNS) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.